CVE-2018-14789
CVE-2018-14789 is a medium-severity vulnerability in Philips Intellispace Cardiovascular with a CVSS 3.x base score of 6.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-428.
Key facts
- Severity: Medium (CVSS 3.x base score 6.7)
- CVSS v2: 4.6
- EPSS exploit prediction: 0% (36th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-428
- Affected product: Philips Intellispace Cardiovascular
- Published:
- Last modified:
Description
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.
Frequently asked questions
- What is CVE-2018-14789?
- In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.
- How severe is CVE-2018-14789?
- CVE-2018-14789 has a CVSS 3.x base score of 6.7, rated medium severity. It is exploitable over local access with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2018-14789 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (36th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2018-14789?
- CVE-2018-14789 primarily affects Philips Intellispace Cardiovascular. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
- How do I fix CVE-2018-14789?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2018-14789 published?
- CVE-2018-14789 was published on 2018-08-22 and last updated on 2026-06-17.
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01
- https://www.usa.philips.com/healthcare/about/customer-support/product-security
Affected products (2)
- cpe:2.3:a:philips:intellispace_cardiovascular:*:*:*:*:*:*:*:*
- cpe:2.3:a:philips:xcelera:*:*:*:*:*:*:*:*
More vulnerabilities in Philips Intellispace Cardiovascular
- CVE-2018-14787 — High (CVSS 7.8): In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior),…
- CVE-2017-14111 — High (CVSS 7.2): The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and…
- CVE-2018-5438 — Medium (CVSS 6.3): Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker…
All CVEs affecting Philips Intellispace Cardiovascular →
Other CWE-428 vulnerabilities
- CVE-2022-50935 — Critical (CVSS 9.8): Flame II HSPA USB Modem contains an unquoted service path vulnerability in its Windows service configuration. Attackers…
- CVE-2023-38408 — Critical (CVSS 9.8): The PKCS#11 feature in ssh-agent in OpenSSH before 9.3p2 has an insufficiently trustworthy search path, leading to…
- CVE-2022-36344 — Critical (CVSS 9.8): An unquoted search path vulnerability exists in 'JustSystems JUST Online Update for J-License' bundled with multiple…
- CVE-2020-9292 — Critical (CVSS 9.8): An unquoted service path vulnerability in the FortiSIEM Windows Agent component may allow an attacker to gain elevated…
- CVE-2019-17658 — Critical (CVSS 9.8): An unquoted service path vulnerability in the FortiClient FortiTray component of FortiClientWindows v6.2.2 and prior…
- CVE-2019-8459 — Critical (CVSS 9.8): Check Point Endpoint Security Client for Windows, with the VPN blade, before version E80.83, starts a process without…